RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 96 filers reported holding RECRO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $763,000 | -12.9% | 167,690 | +56.3% | 0.11% | -25.0% |
| Q1 2020 | $876,000 | -57.7% | 107,272 | -5.0% | 0.15% | -33.6% |
| Q4 2019 | $2,069,000 | +50.0% | 112,892 | -9.3% | 0.22% | +13.8% |
| Q3 2019 | $1,379,000 | +2.2% | 124,449 | -6.2% | 0.20% | +45.2% |
| Q2 2019 | $1,349,000 | +68.0% | 132,681 | -3.2% | 0.14% | +87.5% |
| Q1 2019 | $803,000 | +5.7% | 137,111 | -9.4% | 0.07% | +60.0% |
| Q2 2018 | $760,000 | -51.4% | 151,323 | +6.6% | 0.04% | -55.9% |
| Q1 2018 | $1,563,000 | -6.5% | 141,942 | -21.5% | 0.10% | -3.8% |
| Q4 2017 | $1,672,000 | +11.1% | 180,715 | +7.8% | 0.11% | +12.8% |
| Q3 2017 | $1,505,000 | +72.0% | 167,637 | +34.7% | 0.09% | +54.1% |
| Q2 2017 | $875,000 | +6.4% | 124,491 | +32.4% | 0.06% | +7.0% |
| Q1 2017 | $822,000 | +13.2% | 94,036 | +4.4% | 0.06% | +11.8% |
| Q4 2016 | $726,000 | – | 90,066 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |